Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2021 > Vol 2, №4 (2021) > Clinical types of lung disease in polymyositis and dermatomyositis

Clinical types of lung disease in polymyositis and dermatomyositis

Inna B. Bondarenko , Liubov A. Ponomareva , Elena N. Popova

For citation:


  • Abstract
  • About the Author
  • References

Abstract

The idiopathic inflammatory myopathies are a group of rare, heterogeneous connective tissue disorders characterized by skeletal muscle inflammation. The four main forms of idiopathic inflammatory myopathies are dermatomyositis, polymyositis, inclusion body myositis, and necrotizing immune-mediated myopathy. Each form of myositis, other than inclusion body myositis, can be associated with damage to many organs, including the lungs, heart, joints, and skin. The most often observed damage to the lung tissue with the development of interstitial lung disease, which occurs with or without myositis. The severity of the course varies from mild to severe, with rapid development of respiratory failure. Interstitial lung disease can be fatal in patients with myositis, therefore, it is necessary to assess the damage to the lung tissue in the early stages of the disease.

Key words: dermatomyositis, polymyositis, interstitial lung disease.

About the Author

Inna B. Bondarenko 1 , Liubov A. Ponomareva 1 , Elena N. Popova 1

1 Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia

References

1. Shappley C, Paik JJ, Saketkoo LA. Myositis-Related Interstitial Lung Diseases: Diagnostic Features, Treatment, and Complications. Curr Treatm Opt Rheumatol 2019; 5 (1): 56–83. DOI: 10.1007/s40674-018-0110-6
2. Rosai J. GIST: An Update. Int J Surg Pathol 2003; 11 (3): 177–86. DOI: 10.1177/106689690301100304
3. Bahmer T, Romagnoli M, Girelli F et al. The use of auto-antibody testing in the evaluation of interstitial lung disease (ILD) – A practical approach for the pulmonologist. Respir Med 2016; 113: 80–92. DOI: 10.1016/j.rmed.2016.01.019
4. Witt LJ, Curran JJ, Strek ME. The Diagnosis and Treatment of Antisynthetase Syndrome. Clin Pulm Med 2016; 23 (5): 218–26. DOI: 10.1097/CPM.0000000000000171
5. Debray M-P, Borie R, Revel M-P et al. Interstitial lung disease in anti-synthetase syndrome: Initial and follow-up CT findings. Eur J Radiol 2015; 84: 516–23.
6. Noguchi E, Uruha A, Suzuki S et al. Skeletal Muscle involvement in Antisynthetase Syndrome. JAMA Neurol 2017; 74: 992–9. DOI: 10.1001/jamaNeurol.2017.0934
7. Alyan O, Ozdemir O, Geyik B, Demirkan D. Polymyositis Complicated with Complete Atrioventricular Block: A Case Report and Review of the Literature. Angiology 2003; 54 (6): 729–31. DOI: 10.1177/ 000331970305400615
8. Kagen LJ. Myoglobinemia and myoglobinuria in patients with myositis. Arthritis Rheum 1971; 14 (4): 457–64. DOI: 10.1002/art. 1780140405
9. Fudman EJ, Schnitzer TJ. Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am J Med 1986; 80 (2): 329–32.
10. Schwarz MI, Matthay RA, Sahn SA et al. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) 1976; 55 (1): 89–104. DOI: 10.1097/00005792-197601000-00005. PMID: 1246203.
11. Ikezoe J, Takeuchi N, Kido S et al. Dynamic Range Control Processing of Digital Chest Images: A Clinical Evaluation. Acta Radiologica 1996; 37 (1P1): 107–15. DOI: 10.1177/02841851960371P121
12. Paspalaki PK, Mihailidou EP, Bitsori M et al. Polyomyositis and myocarditis associated with acquired toxoplasmosis in an immunocompetent girl. BMC Musculoskelet Disord 2001; 2: 8. DOI: 10.1186/1471-2474-2-8
13. Uruha A, Noguchi S, Hayashi YK et al. Hepatitis C virus infection in inclusion body myositis: A case-control study. Neurology 2016; 86 (3): 211–7. DOI: 10.1212/WNL.0000000000002291
14. Lloyd TE, Pinal-Fernandez I, Michelle EH et al. Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients. Neurology 2017; 88 (15): 1454–60. DOI:10.1212/WNL. 0000000000003821
15. Courtney AE, C Doherty C, Herron B et al. Acute polymyositis following renal transplantation. Am J Transplant 2004; 4 (7): 1204–7. DOI: 10.1111/j.1600-6143.2004.00489.x. PMID: 15196084.
16. Mouthon L. Physiopathology of polymyositis and dermatomyositis, mechanism of action of intravenous immunoglobulins. Rev Med Interne 2004; 25 (Spec. 3): 10–2. PMID: 15842099.
17. Rider LG, Katz JD, Jones OY. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am. 2013; 39 (4): 877–904. DOI: 10.1016/ j.rdc.2013.06.001
18. Li Y, Gao X, Li Y et al. Predictors and Mortality of Rapidly Progressive Interstitial Lung Disease in Patients With Idiopathic Inflammatory Myopathy: A Series of 474 Patients. Front Med (Lausanne) 2020; 7: 363. DOI: 10.3389/fmed.2020.00363
19. Бондаренко И.Б., Мухин Н.А., Попова Е.Н. и др. Поражение легких при полимиозите и дерматомиозите. Клиническая медицина. 1998; 2: 20–4. 
[Bondarenko I.B., Mukhin N.A., Popova E.N. et al. Porazhenie legkikh pri polimiozite i dermatomiozite. Klinicheskaia meditsina. 1998; 2: 20–4 (in Russian).]
20. Schmidt J. Current Classification and Management of Inflammatory Myopathies. J Neuromuscul Dis 2018; 5 (2): 109–29. DOI:10.3233/JND-180308
21. Koksal D, Koksal AS, Gurakar A. Pulmonary Manifestations among Patients with Primary Biliary Cirrhosis. J Clin Transl Hepatol 2016; 4 (3): 258–62. DOI: 10.14218/JCTH.2016.00024
22. Tanida S, Takemura M, Mizoshita T et al. Organizing Pneumonia in a Patient with Quiescent Crohn's Disease. Case Rep Gastrointest Med 2016; 2016: 8129864. DOI: 10.1155/2016/8129864
23. Saketkoo LA, Ascherman DP, Cottin V et al. Interstitial Lung Disease in Idiopathic Inflammatory Myopathy. Curr Rheumatol Rev 2010; 6 (2): 108–19. DOI: 10.2174/157339710791330740
24. Tanida S, Takemura M, Mizoshita T et al. Organizing Pneumonia in a Patient with Quiescent Crohn's Disease. Case Rep Gastrointest Med 2016; 2016: 8129864. DOI: 10.1155/2016/8129864
25. Radzikowska E, Roży A, Jaguś P et al. Cryptogenic Organizing Pneumonia: IL-1β, IL-6, IL-8, and TGF- β1 Serum Concentrations and Response to Clarithromycin Treatment. Adv Exp Med Biol 2016; 911: 77–85. DOI: 10.1007/5584_2016_223
26. Fujisawa T, Hozumi H, Kono M et al. Prognostic factors for myositis-associated interstitial lung disease. PLoS One 2014; 9 (6): e98824. DOI:10.1371/journal.pone.0098824
27. Douglas WW, Tazelaar HD, Hartman TE et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001; 164 (7): 1182–5. DOI: 10.1164/ajrccm.164.7.2103110
28. Lega JC, Reynaud Q, Belot A et al. Idiopathic inflammatory myopathies and the lung. Eur Respir Rev 2015; 24 (136): 216–38. DOI: 10.1183/16000617.00002015
29. Barsotti S, Lundberg IE. Current Treatment for Myositis. Curr Treatm Opt Rheumatol 2018; 4 (4): 299–315. DOI: 10.1007/s40674-018-0106-2
30. Tjärnlund A, Tang Q, Wick C et al. Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial. Ann Rheum Dis 2018; 77: 55–62. DOI: 10.1136/annrheumdis-2017-211751
31. Muscle Study Group TMS A randomized, pilot trial of etanercept in dermatomyositis. Ann Neurol 2011; 70: 427–36. DOI: 10.1002/ana. 22477
32. András C, Bodoki L, Nagy-Vincze M et al. Retrospective Analysis of Cancer-Associated Myositis Patients over the Past 3 Decades in a Hungarian Myositis Cohort. Pathol Oncol Res 2020; 26: 1749–55. DOI: 10.1007/s12253-019-00756-4
33. nterstitsial'nye bolezni legkikh. Ed. N.A. Mukhin. Moscow: Litterra, 2017 (in Russian).

For citation:Bondarenko I.B., Ponomareva L.A., Popova E.N. Clinical types of lung disease in polymyositis and dermatomyositis. Clinical review for general practice. 2021; 4: 34–39. DOI: 10.47407/kr2021.2.4.00058


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru